Covered recipient · General Payments record
MUHAMMAD A SHOAIB
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$10,119.24
- Reported across 668 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.42 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.52 | 15 |
| Teva Pharmaceuticals USA, Inc. | $68.81 | 4 |
| UCB, Inc. | $61.52 | 3 |
| Lundbeck LLC | $42.69 | 2 |
| LivaNova USA, Inc. | $35.66 | 1 |
| EISAI INC. | $26.21 | 1 |
| Biogen, Inc. | $21.28 | 1 |
| EMD Serono, Inc. | $19.25 | 1 |
| Sumitomo Pharma America, Inc. | $17.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.56 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090332 | CMS |
| ABBVIE INC. | $12.86 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090334 | CMS |
| ABBVIE INC. | $7.71 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090336 | CMS |
| ABBVIE INC. | $18.94 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090338 | CMS |
| ABBVIE INC. | $20.94 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090340 | CMS |
| ABBVIE INC. | $5.76 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090342 | CMS |
| ABBVIE INC. | $7.91 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090344 | CMS |
| ABBVIE INC. | $14.69 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090346 | CMS |
| ABBVIE INC. | $17.20 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090348 | CMS |
| ABBVIE INC. | $2.94 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090350 | CMS |
| ABBVIE INC. | $2.33 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090352 | CMS |
| ABBVIE INC. | $5.34 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090354 | CMS |
| ABBVIE INC. | $11.68 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090356 | CMS |
| ABBVIE INC. | $3.84 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090358 | CMS |
| ABBVIE INC. | $23.82 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106090360 | CMS |
| Biogen, Inc. | $21.28 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104819592 | CMS |
| Eisai Inc. | $26.21 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110768461 | CMS |
| EMD Serono, Inc. | $19.25 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120231365 | CMS |
| LivaNova USA, Inc. | $35.66 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152794933 | CMS |
| Lundbeck LLC | $23.13 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145969044 | CMS |
| Lundbeck LLC | $19.56 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145969046 | CMS |
| Sumitomo Pharma America, Inc. | $17.48 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148919695 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.74 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636823 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.52 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636919 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.35 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636939 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.20 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636951 | CMS |
| UCB, Inc. | $23.81 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143054903 | CMS |
| UCB, Inc. | $15.30 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143054905 | CMS |
| UCB, Inc. | $22.41 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143054907 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.